TWI232104B

TWI232104B - Compositions for the treatment of viral infections

Compositions for the treatment of viral infections Download PDF

Info

Publication number: TWI232104B
Authority: TW; Taiwan
Prior art keywords: water; group; acid; day; hiv
Prior art date: 1996-07-10

Application number

TW86109695A

Other languages

English (en)

Chinese (zh)

Inventor

Hsiu-Hsien Tsai

Shie-Ming Hwang

Original Assignee

Sage R & D

Priority date

1996-07-10

Filing date

1997-07-09

Publication date

2005-05-11

1997-07-09 Application filed by Sage R & D filed Critical Sage R & D

2005-05-11 Application granted granted Critical

2005-05-11 Publication of TWI232104B publication Critical patent/TWI232104B/zh

Links

239000000203 mixture Substances 0.000 title claims abstract description 151
238000011282 treatment Methods 0.000 title claims abstract description 67
208000036142 Viral infection Diseases 0.000 title claims description 16
230000009385 viral infection Effects 0.000 title claims description 16
241000700605 Viruses Species 0.000 claims abstract description 71
241000725303 Human immunodeficiency virus Species 0.000 claims abstract description 64
241000700721 Hepatitis B virus Species 0.000 claims abstract description 41
241000711549 Hepacivirus C Species 0.000 claims abstract description 30
241000282412 Homo Species 0.000 claims abstract description 24
241000196324 Embryophyta Species 0.000 claims description 119
244000179560 Prunella vulgaris Species 0.000 claims description 44
235000010674 Prunella vulgaris Nutrition 0.000 claims description 35
239000003814 drug Substances 0.000 claims description 29
240000001341 Reynoutria japonica Species 0.000 claims description 27
235000018167 Reynoutria japonica Nutrition 0.000 claims description 26
239000000843 powder Substances 0.000 claims description 24
241001570521 Lonicera periclymenum Species 0.000 claims description 22
244000025254 Cannabis sativa Species 0.000 claims description 20
241000555712 Forsythia Species 0.000 claims description 20
239000003795 chemical substances by application Substances 0.000 claims description 18
241000830535 Ligustrum lucidum Species 0.000 claims description 16
208000015181 infectious disease Diseases 0.000 claims description 14
241000915604 Scutellaria barbata Species 0.000 claims description 13
PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 claims description 13
240000001659 Oldenlandia diffusa Species 0.000 claims description 12
241000207929 Scutellaria Species 0.000 claims description 12
235000013399 edible fruits Nutrition 0.000 claims description 12
229910052737 gold Inorganic materials 0.000 claims description 12
239000010931 gold Substances 0.000 claims description 12
241000334154 Isatis tinctoria Species 0.000 claims description 11
239000002689 soil Substances 0.000 claims description 10
235000009508 confectionery Nutrition 0.000 claims description 9
235000016709 nutrition Nutrition 0.000 claims description 9
241000132536 Cirsium Species 0.000 claims description 8
241000729173 Cirsium japonicum Species 0.000 claims description 8
241000972673 Phellodendron amurense Species 0.000 claims description 8
240000004534 Scutellaria baicalensis Species 0.000 claims description 8
235000017089 Scutellaria baicalensis Nutrition 0.000 claims description 8
241000576429 Forsythia suspensa Species 0.000 claims description 7
244000167230 Lonicera japonica Species 0.000 claims description 7
235000017617 Lonicera japonica Nutrition 0.000 claims description 7
239000000825 pharmaceutical preparation Substances 0.000 claims description 7
241001453842 Athyrium Species 0.000 claims description 6
241001148786 Cyathea lepifera Species 0.000 claims description 6
241001660866 Cyrtomium falcatum Species 0.000 claims description 6
241001226187 Cyrtomium fortunei Species 0.000 claims description 6
235000002594 Solanum nigrum Nutrition 0.000 claims description 6
244000061457 Solanum nigrum Species 0.000 claims description 6
241000006398 Woodwardia orientalis Species 0.000 claims description 6
239000002775 capsule Substances 0.000 claims description 6
239000007937 lozenge Substances 0.000 claims description 6
229940127557 pharmaceutical product Drugs 0.000 claims description 6
241000002452 Dichondra micrantha Species 0.000 claims description 5
241000594394 Hedyotis Species 0.000 claims description 5
244000020551 Helianthus annuus Species 0.000 claims description 5
235000003222 Helianthus annuus Nutrition 0.000 claims description 5
241001574604 Scutellaria dependens Species 0.000 claims description 5
235000013361 beverage Nutrition 0.000 claims description 5
244000015329 Aeginetia indica Species 0.000 claims description 4
235000014624 Aeginetia indica Nutrition 0.000 claims description 4
241001148764 Blechnopsis orientalis Species 0.000 claims description 4
241000506964 Dichondra repens Species 0.000 claims description 4
241001198924 Forsythia koreana Species 0.000 claims description 4
241000100289 Lonicera confusa Species 0.000 claims description 4
241000294180 Osmunda japonica Species 0.000 claims description 4
244000181366 Polygonum runcinatum Species 0.000 claims description 4
241001146210 Senecio scandens Species 0.000 claims description 4
241000513972 Woodwardia unigemmata Species 0.000 claims description 4
239000004615 ingredient Substances 0.000 claims description 4
241001198934 Forsythia viridissima Species 0.000 claims description 3
244000297531 Lespedeza cuneata Species 0.000 claims description 3
241000735234 Ligustrum Species 0.000 claims description 3
241000201320 Ligustrum japonicum Species 0.000 claims description 3
241000257673 Strobilanthes cusia Species 0.000 claims description 3
230000002458 infectious effect Effects 0.000 claims description 3
239000009472 lonicerae flos Substances 0.000 claims description 3
241000382362 Persicaria tinctoria Species 0.000 claims description 2
241001079007 Phellodendron chinense Species 0.000 claims description 2
241001317551 Prunella asiatica Species 0.000 claims description 2
241001148769 Woodwardia Species 0.000 claims description 2
230000008859 change Effects 0.000 claims description 2
241000196133 Dryopteris Species 0.000 claims 3
241000393483 Dryopteris crassirhizoma Species 0.000 claims 3
244000235229 Striga lutea Species 0.000 claims 3
241001313857 Bletilla striata Species 0.000 claims 2
241000721490 Peperomia Species 0.000 claims 2
241000205407 Polygonum Species 0.000 claims 2
239000000084 colloidal system Substances 0.000 claims 2
241000332371 Abutilon x hybridum Species 0.000 claims 1
241000221079 Euphorbia <genus> Species 0.000 claims 1
240000007594 Oryza sativa Species 0.000 claims 1
235000007164 Oryza sativa Nutrition 0.000 claims 1
241000972672 Phellodendron Species 0.000 claims 1
241000382353 Pupa Species 0.000 claims 1
244000184734 Pyrus japonica Species 0.000 claims 1
241000543657 Triglochin Species 0.000 claims 1
208000032839 leukemia Diseases 0.000 claims 1
235000009566 rice Nutrition 0.000 claims 1
239000000284 extract Substances 0.000 abstract description 179
238000000034 method Methods 0.000 abstract description 44
241000411851 herbal medicine Species 0.000 abstract description 42
230000000840 anti-viral effect Effects 0.000 abstract description 30
239000000969 carrier Substances 0.000 abstract description 23
208000005176 Hepatitis C Diseases 0.000 abstract description 18
238000000338 in vitro Methods 0.000 abstract description 18
208000030507 AIDS Diseases 0.000 abstract description 15
241001465754 Metazoa Species 0.000 abstract description 7
241000714177 Murine leukemia virus Species 0.000 abstract description 7
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 231
239000002253 acid Substances 0.000 description 164
230000000694 effects Effects 0.000 description 163
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 146
230000005764 inhibitory process Effects 0.000 description 146
239000002244 precipitate Substances 0.000 description 139
230000036436 anti-hiv Effects 0.000 description 89
239000000243 solution Substances 0.000 description 68
238000011993 High Performance Size Exclusion Chromatography Methods 0.000 description 66
239000000523 sample Substances 0.000 description 66
239000006228 supernatant Substances 0.000 description 66
238000012360 testing method Methods 0.000 description 66
235000008216 herbs Nutrition 0.000 description 64
230000002079 cooperative effect Effects 0.000 description 52
230000035755 proliferation Effects 0.000 description 52
239000012632 extractable Substances 0.000 description 49
239000004480 active ingredient Substances 0.000 description 42
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 41
201000010099 disease Diseases 0.000 description 40
239000000126 substance Substances 0.000 description 31
150000003863 ammonium salts Chemical class 0.000 description 30
210000004027 cell Anatomy 0.000 description 29
230000003013 cytotoxicity Effects 0.000 description 27
231100000135 cytotoxicity Toxicity 0.000 description 27
239000000463 material Substances 0.000 description 25
230000001988 toxicity Effects 0.000 description 25
231100000419 toxicity Toxicity 0.000 description 25
HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 24
LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 21
239000002953 phosphate buffered saline Substances 0.000 description 21
239000012071 phase Substances 0.000 description 20
238000003556 assay Methods 0.000 description 19
208000002672 hepatitis B Diseases 0.000 description 19
WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 18
229940079593 drug Drugs 0.000 description 18
230000007935 neutral effect Effects 0.000 description 18
230000002829 reductive effect Effects 0.000 description 18
QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 15
230000000844 anti-bacterial effect Effects 0.000 description 15
238000011287 therapeutic dose Methods 0.000 description 15
150000001875 compounds Chemical class 0.000 description 14
239000007924 injection Substances 0.000 description 14
238000002347 injection Methods 0.000 description 14
238000002360 preparation method Methods 0.000 description 14
238000004007 reversed phase HPLC Methods 0.000 description 14
102000014150 Interferons Human genes 0.000 description 13
108010050904 Interferons Proteins 0.000 description 13
206010028980 Neoplasm Diseases 0.000 description 13
239000007864 aqueous solution Substances 0.000 description 13
238000004128 high performance liquid chromatography Methods 0.000 description 13
238000002329 infrared spectrum Methods 0.000 description 13
229940079322 interferon Drugs 0.000 description 13
241000713772 Human immunodeficiency virus 1 Species 0.000 description 12
OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 12
230000002378 acidificating effect Effects 0.000 description 12
201000011510 cancer Diseases 0.000 description 12
239000006143 cell culture medium Substances 0.000 description 12
238000004587 chromatography analysis Methods 0.000 description 12
238000000605 extraction Methods 0.000 description 12
231100000252 nontoxic Toxicity 0.000 description 12
230000003000 nontoxic effect Effects 0.000 description 12
210000002966 serum Anatomy 0.000 description 12
238000003860 storage Methods 0.000 description 12
108010082126 Alanine transaminase Proteins 0.000 description 11
108010003415 Aspartate Aminotransferases Proteins 0.000 description 11
102000004625 Aspartate Aminotransferases Human genes 0.000 description 11
238000004458 analytical method Methods 0.000 description 11
230000002401 inhibitory effect Effects 0.000 description 11
VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 11
239000000725 suspension Substances 0.000 description 11
238000005119 centrifugation Methods 0.000 description 10
210000004185 liver Anatomy 0.000 description 10
238000003809 water extraction Methods 0.000 description 10
CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 9
150000007513 acids Chemical class 0.000 description 9
210000004698 lymphocyte Anatomy 0.000 description 9
239000002245 particle Substances 0.000 description 9
238000001556 precipitation Methods 0.000 description 9
QWAXKHKRTORLEM-UGJKXSETSA-N saquinavir Chemical compound C([C@@H]([C@H](O)CN1C[C@H]2CCCC[C@H]2C[C@H]1C(=O)NC(C)(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)C=1N=C2C=CC=CC2=CC=1)C1=CC=CC=C1 QWAXKHKRTORLEM-UGJKXSETSA-N 0.000 description 9
239000002904 solvent Substances 0.000 description 9
206010016654 Fibrosis Diseases 0.000 description 8
238000010521 absorption reaction Methods 0.000 description 8
239000012670 alkaline solution Substances 0.000 description 8
230000007882 cirrhosis Effects 0.000 description 8
208000019425 cirrhosis of liver Diseases 0.000 description 8
238000009826 distribution Methods 0.000 description 8
208000006454 hepatitis Diseases 0.000 description 8
239000013641 positive control Substances 0.000 description 8
239000000047 product Substances 0.000 description 8
239000007858 starting material Substances 0.000 description 8
VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 7
208000031886 HIV Infections Diseases 0.000 description 7
235000011114 ammonium hydroxide Nutrition 0.000 description 7
231100000283 hepatitis Toxicity 0.000 description 7
238000005259 measurement Methods 0.000 description 7
230000009467 reduction Effects 0.000 description 7
150000003839 salts Chemical class 0.000 description 7
230000001629 suppression Effects 0.000 description 7
238000002560 therapeutic procedure Methods 0.000 description 7
229940098465 tincture Drugs 0.000 description 7
230000003612 virological effect Effects 0.000 description 7
208000037357 HIV infectious disease Diseases 0.000 description 6
KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 6
206010030113 Oedema Diseases 0.000 description 6
238000003916 acid precipitation Methods 0.000 description 6
RXVGBQCEAQZMLW-UHFFFAOYSA-N alpha-solanine Natural products CC1CCC2C(C)C3C(CC4C5CC=C6CC(CCC6(C)C5CCC34C)OC7OC(CO)C(O)C(OC8OC(CO)C(O)C(O)C8O)C7OC9OC(CO)C(O)C(O)C9O)N2C1 RXVGBQCEAQZMLW-UHFFFAOYSA-N 0.000 description 6
230000003602 anti-herpes Effects 0.000 description 6
239000002585 base Substances 0.000 description 6
238000009835 boiling Methods 0.000 description 6
239000000872 buffer Substances 0.000 description 6
229910052799 carbon Inorganic materials 0.000 description 6
230000007423 decrease Effects 0.000 description 6
239000006185 dispersion Substances 0.000 description 6
231100000673 dose–response relationship Toxicity 0.000 description 6
238000004108 freeze drying Methods 0.000 description 6
230000035876 healing Effects 0.000 description 6
238000010438 heat treatment Methods 0.000 description 6
208000033519 human immunodeficiency virus infectious disease Diseases 0.000 description 6
238000011068 loading method Methods 0.000 description 6
238000011160 research Methods 0.000 description 6
ZGVSETXHNHBTRK-OTYSSXIJSA-N solanine Chemical compound O([C@H]1[C@@H](O)[C@@H](CO)O[C@H]([C@@H]1O[C@@H]1[C@@H]([C@H](O)[C@@H](O)[C@H](C)O1)O)O[C@@H]1CC2=CC[C@H]3[C@@H]4C[C@@H]5N6C[C@@H](C)CC[C@@H]6[C@H]([C@@H]5[C@@]4(C)CC[C@@H]3[C@@]2(C)CC1)C)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O ZGVSETXHNHBTRK-OTYSSXIJSA-N 0.000 description 6
229940031352 solanine Drugs 0.000 description 6
241000894007 species Species 0.000 description 6
238000004448 titration Methods 0.000 description 6
241000208838 Asteraceae Species 0.000 description 5
206010012735 Diarrhoea Diseases 0.000 description 5
102000004190 Enzymes Human genes 0.000 description 5
108090000790 Enzymes Proteins 0.000 description 5
241000124008 Mammalia Species 0.000 description 5
208000000474 Poliomyelitis Diseases 0.000 description 5
206010000269 abscess Diseases 0.000 description 5
239000003513 alkali Substances 0.000 description 5
230000003172 anti-dna Effects 0.000 description 5
230000000798 anti-retroviral effect Effects 0.000 description 5
210000004369 blood Anatomy 0.000 description 5
239000008280 blood Substances 0.000 description 5
231100000433 cytotoxic Toxicity 0.000 description 5
230000001472 cytotoxic effect Effects 0.000 description 5
238000005516 engineering process Methods 0.000 description 5
238000002474 experimental method Methods 0.000 description 5
230000007774 longterm Effects 0.000 description 5
230000014759 maintenance of location Effects 0.000 description 5
150000007524 organic acids Chemical class 0.000 description 5
238000012856 packing Methods 0.000 description 5
210000005105 peripheral blood lymphocyte Anatomy 0.000 description 5
239000004033 plastic Substances 0.000 description 5
230000002265 prevention Effects 0.000 description 5
150000003648 triterpenes Chemical class 0.000 description 5
238000002211 ultraviolet spectrum Methods 0.000 description 5
208000004232 Enteritis Diseases 0.000 description 4
206010018612 Gonorrhoea Diseases 0.000 description 4
208000007514 Herpes zoster Diseases 0.000 description 4
241000700588 Human alphaherpesvirus 1 Species 0.000 description 4
LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 4
206010037660 Pyrexia Diseases 0.000 description 4
241000780602 Senecio Species 0.000 description 4
YZCKVEUIGOORGS-NJFSPNSNSA-N Tritium Chemical compound [3H] YZCKVEUIGOORGS-NJFSPNSNSA-N 0.000 description 4
108010067390 Viral Proteins Proteins 0.000 description 4
230000003110 anti-inflammatory effect Effects 0.000 description 4
230000003247 decreasing effect Effects 0.000 description 4
WHBIGIKBNXZKFE-UHFFFAOYSA-N delavirdine Chemical compound CC(C)NC1=CC=CN=C1N1CCN(C(=O)C=2NC3=CC=C(NS(C)(=O)=O)C=C3C=2)CC1 WHBIGIKBNXZKFE-UHFFFAOYSA-N 0.000 description 4
208000001848 dysentery Diseases 0.000 description 4
210000005069 ears Anatomy 0.000 description 4
238000000921 elemental analysis Methods 0.000 description 4
239000003480 eluent Substances 0.000 description 4
238000001704 evaporation Methods 0.000 description 4
230000008020 evaporation Effects 0.000 description 4
238000001914 filtration Methods 0.000 description 4
229940124600 folk medicine Drugs 0.000 description 4
235000013350 formula milk Nutrition 0.000 description 4
239000012634 fragment Substances 0.000 description 4
239000011521 glass Substances 0.000 description 4
208000001786 gonorrhea Diseases 0.000 description 4
238000011194 good manufacturing practice Methods 0.000 description 4
230000012010 growth Effects 0.000 description 4
230000006872 improvement Effects 0.000 description 4
239000007788 liquid Substances 0.000 description 4
201000007270 liver cancer Diseases 0.000 description 4
208000019423 liver disease Diseases 0.000 description 4
230000003908 liver function Effects 0.000 description 4
208000014018 liver neoplasm Diseases 0.000 description 4
238000002156 mixing Methods 0.000 description 4
108090000623 proteins and genes Proteins 0.000 description 4
238000000746 purification Methods 0.000 description 4
239000002994 raw material Substances 0.000 description 4
238000000926 separation method Methods 0.000 description 4
208000024891 symptom Diseases 0.000 description 4
231100000331 toxic Toxicity 0.000 description 4
230000002588 toxic effect Effects 0.000 description 4
231100000820 toxicity test Toxicity 0.000 description 4
229910052722 tritium Inorganic materials 0.000 description 4
230000005727 virus proliferation Effects 0.000 description 4
238000005406 washing Methods 0.000 description 4
QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 3
206010003011 Appendicitis Diseases 0.000 description 3
101100328518 Caenorhabditis elegans cnt-1 gene Proteins 0.000 description 3
OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 3
208000000419 Chronic Hepatitis B Diseases 0.000 description 3
208000034656 Contusions Diseases 0.000 description 3
244000018436 Coriandrum sativum Species 0.000 description 3
235000002787 Coriandrum sativum Nutrition 0.000 description 3
238000005033 Fourier transform infrared spectroscopy Methods 0.000 description 3
208000034507 Haematemesis Diseases 0.000 description 3
206010020772 Hypertension Diseases 0.000 description 3
241000334160 Isatis Species 0.000 description 3
206010023126 Jaundice Diseases 0.000 description 3
201000005505 Measles Diseases 0.000 description 3
241000699670 Mus sp. Species 0.000 description 3
241000286209 Phasianidae Species 0.000 description 3
244000269722 Thea sinensis Species 0.000 description 3
102000003929 Transaminases Human genes 0.000 description 3
108090000340 Transaminases Proteins 0.000 description 3
102000004357 Transferases Human genes 0.000 description 3
108090000992 Transferases Proteins 0.000 description 3
WREGKURFCTUGRC-POYBYMJQSA-N Zalcitabine Chemical compound O=C1N=C(N)C=CN1[C@@H]1O[C@H](CO)CC1 WREGKURFCTUGRC-POYBYMJQSA-N 0.000 description 3
230000002411 adverse Effects 0.000 description 3
238000007605 air drying Methods 0.000 description 3
230000001754 anti-pyretic effect Effects 0.000 description 3
239000000427 antigen Substances 0.000 description 3
108091007433 antigens Proteins 0.000 description 3
102000036639 antigens Human genes 0.000 description 3
239000002221 antipyretic Substances 0.000 description 3
239000003443 antiviral agent Substances 0.000 description 3
239000006286 aqueous extract Substances 0.000 description 3
239000008346 aqueous phase Substances 0.000 description 3
239000007900 aqueous suspension Substances 0.000 description 3
235000019658 bitter taste Nutrition 0.000 description 3
239000003153 chemical reaction reagent Substances 0.000 description 3
239000012141 concentrate Substances 0.000 description 3
230000006378 damage Effects 0.000 description 3
238000010790 dilution Methods 0.000 description 3
239000012895 dilution Substances 0.000 description 3
229940042399 direct acting antivirals protease inhibitors Drugs 0.000 description 3
239000002934 diuretic Substances 0.000 description 3
ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 3
150000004676 glycans Chemical class 0.000 description 3
238000009396 hybridization Methods 0.000 description 3
239000002198 insoluble material Substances 0.000 description 3
238000009434 installation Methods 0.000 description 3
238000004519 manufacturing process Methods 0.000 description 3
238000002844 melting Methods 0.000 description 3
230000008018 melting Effects 0.000 description 3
239000012528 membrane Substances 0.000 description 3
238000001471 micro-filtration Methods 0.000 description 3
239000013642 negative control Substances 0.000 description 3
231100000065 noncytotoxic Toxicity 0.000 description 3
230000002020 noncytotoxic effect Effects 0.000 description 3
238000002414 normal-phase solid-phase extraction Methods 0.000 description 3
235000005985 organic acids Nutrition 0.000 description 3
239000003960 organic solvent Substances 0.000 description 3
239000008188 pellet Substances 0.000 description 3
239000000137 peptide hydrolase inhibitor Substances 0.000 description 3
239000000419 plant extract Substances 0.000 description 3
238000003752 polymerase chain reaction Methods 0.000 description 3
229920001282 polysaccharide Polymers 0.000 description 3
239000005017 polysaccharide Substances 0.000 description 3
102000004169 proteins and genes Human genes 0.000 description 3
230000010076 replication Effects 0.000 description 3
229910052702 rhenium Inorganic materials 0.000 description 3
WUAPFZMCVAUBPE-UHFFFAOYSA-N rhenium atom Chemical compound [Re] WUAPFZMCVAUBPE-UHFFFAOYSA-N 0.000 description 3
238000001694 spray drying Methods 0.000 description 3
238000000108 ultra-filtration Methods 0.000 description 3
239000003643 water by type Substances 0.000 description 3
230000003442 weekly effect Effects 0.000 description 3
241000252349 Acipenser transmontanus Species 0.000 description 2
208000006154 Chronic hepatitis C Diseases 0.000 description 2
206010010904 Convulsion Diseases 0.000 description 2
244000052363 Cynodon dactylon Species 0.000 description 2
201000000297 Erysipelas Diseases 0.000 description 2
206010015958 Eye pain Diseases 0.000 description 2
241001198917 Forsythia ovata Species 0.000 description 2
208000007882 Gastritis Diseases 0.000 description 2
WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
206010018498 Goitre Diseases 0.000 description 2
206010019233 Headaches Diseases 0.000 description 2
206010019909 Hernia Diseases 0.000 description 2
208000009889 Herpes Simplex Diseases 0.000 description 2
206010061218 Inflammation Diseases 0.000 description 2
102100034343 Integrase Human genes 0.000 description 2
229910017974 NH40H Inorganic materials 0.000 description 2
239000004677 Nylon Substances 0.000 description 2
208000002193 Pain Diseases 0.000 description 2
201000007100 Pharyngitis Diseases 0.000 description 2
ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
244000233952 Polygonum bistorta Species 0.000 description 2
235000014258 Polygonum bistorta Nutrition 0.000 description 2
108010092799 RNA-directed DNA polymerase Proteins 0.000 description 2
241000700159 Rattus Species 0.000 description 2
208000034189 Sclerosis Diseases 0.000 description 2
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
241000191967 Staphylococcus aureus Species 0.000 description 2
235000016639 Syzygium aromaticum Nutrition 0.000 description 2
VQQVWGVXDIPORV-UHFFFAOYSA-N Tryptanthrine Chemical compound C1=CC=C2C(=O)N3C4=CC=CC=C4C(=O)C3=NC2=C1 VQQVWGVXDIPORV-UHFFFAOYSA-N 0.000 description 2
229910052770 Uranium Inorganic materials 0.000 description 2
239000013543 active substance Substances 0.000 description 2
230000001154 acute effect Effects 0.000 description 2
230000007059 acute toxicity Effects 0.000 description 2
231100000403 acute toxicity Toxicity 0.000 description 2
239000003242 anti bacterial agent Substances 0.000 description 2
-1 anti-inflammatory Substances 0.000 description 2
239000002260 anti-inflammatory agent Substances 0.000 description 2
229940121363 anti-inflammatory agent Drugs 0.000 description 2
230000000538 anti-polioviral effect Effects 0.000 description 2
229940088710 antibiotic agent Drugs 0.000 description 2
239000000729 antidote Substances 0.000 description 2
229910052785 arsenic Inorganic materials 0.000 description 2
206010003246 arthritis Diseases 0.000 description 2
208000006673 asthma Diseases 0.000 description 2
239000010231 banlangen Substances 0.000 description 2
WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
230000015572 biosynthetic process Effects 0.000 description 2
244000309464 bull Species 0.000 description 2
230000003196 chaotropic effect Effects 0.000 description 2
150000005829 chemical entities Chemical class 0.000 description 2
239000004927 clay Substances 0.000 description 2
230000007012 clinical effect Effects 0.000 description 2
230000009519 contusion Effects 0.000 description 2
230000036461 convulsion Effects 0.000 description 2
238000001816 cooling Methods 0.000 description 2
238000012937 correction Methods 0.000 description 2
230000002498 deadly effect Effects 0.000 description 2
230000034994 death Effects 0.000 description 2
238000001514 detection method Methods 0.000 description 2
208000010643 digestive system disease Diseases 0.000 description 2
238000004090 dissolution Methods 0.000 description 2
229940030606 diuretics Drugs 0.000 description 2
238000001035 drying Methods 0.000 description 2
208000030533 eye disease Diseases 0.000 description 2
238000011049 filling Methods 0.000 description 2
239000000706 filtrate Substances 0.000 description 2
235000013305 food Nutrition 0.000 description 2
239000008103 glucose Substances 0.000 description 2
201000003872 goiter Diseases 0.000 description 2
231100000869 headache Toxicity 0.000 description 2
230000036541 health Effects 0.000 description 2
208000005252 hepatitis A Diseases 0.000 description 2
208000010710 hepatitis C virus infection Diseases 0.000 description 2
238000000099 in vitro assay Methods 0.000 description 2
238000001727 in vivo Methods 0.000 description 2
238000011534 incubation Methods 0.000 description 2
CBVCZFGXHXORBI-PXQQMZJSSA-N indinavir Chemical compound C([C@H](N(CC1)C[C@@H](O)C[C@@H](CC=2C=CC=CC=2)C(=O)N[C@H]2C3=CC=CC=C3C[C@H]2O)C(=O)NC(C)(C)C)N1CC1=CC=CN=C1 CBVCZFGXHXORBI-PXQQMZJSSA-N 0.000 description 2
230000004054 inflammatory process Effects 0.000 description 2
206010022000 influenza Diseases 0.000 description 2
239000003112 inhibitor Substances 0.000 description 2
239000002054 inoculum Substances 0.000 description 2
238000007918 intramuscular administration Methods 0.000 description 2
238000001990 intravenous administration Methods 0.000 description 2
JTEGQNOMFQHVDC-NKWVEPMBSA-N lamivudine Chemical compound O=C1N=C(N)C=CN1[C@H]1O[C@@H](CO)SC1 JTEGQNOMFQHVDC-NKWVEPMBSA-N 0.000 description 2
238000004811 liquid chromatography Methods 0.000 description 2
208000004396 mastitis Diseases 0.000 description 2
239000011159 matrix material Substances 0.000 description 2
239000002609 medium Substances 0.000 description 2
210000004080 milk Anatomy 0.000 description 2
NQDJXKOVJZTUJA-UHFFFAOYSA-N nevirapine Chemical compound C12=NC=CC=C2C(=O)NC=2C(C)=CC=NC=2N1C1CC1 NQDJXKOVJZTUJA-UHFFFAOYSA-N 0.000 description 2
231100001083 no cytotoxicity Toxicity 0.000 description 2
230000035764 nutrition Effects 0.000 description 2
229920001778 nylon Polymers 0.000 description 2
230000036407 pain Effects 0.000 description 2
230000036961 partial effect Effects 0.000 description 2
244000052769 pathogen Species 0.000 description 2
230000001717 pathogenic effect Effects 0.000 description 2
230000002093 peripheral effect Effects 0.000 description 2
229920000642 polymer Polymers 0.000 description 2
239000011148 porous material Substances 0.000 description 2
230000003449 preventive effect Effects 0.000 description 2
230000004044 response Effects 0.000 description 2
NCDNCNXCDXHOMX-XGKFQTDJSA-N ritonavir Chemical compound N([C@@H](C(C)C)C(=O)N[C@H](C[C@H](O)[C@H](CC=1C=CC=CC=1)NC(=O)OCC=1SC=NC=1)CC=1C=CC=CC=1)C(=O)N(C)CC1=CSC(C(C)C)=N1 NCDNCNXCDXHOMX-XGKFQTDJSA-N 0.000 description 2
239000003419 rna directed dna polymerase inhibitor Substances 0.000 description 2
239000012488 sample solution Substances 0.000 description 2
229960001852 saquinavir Drugs 0.000 description 2
239000013049 sediment Substances 0.000 description 2
208000017520 skin disease Diseases 0.000 description 2
229910000030 sodium bicarbonate Inorganic materials 0.000 description 2
239000007787 solid Substances 0.000 description 2
239000002594 sorbent Substances 0.000 description 2
238000001228 spectrum Methods 0.000 description 2
230000000638 stimulation Effects 0.000 description 2
238000003756 stirring Methods 0.000 description 2
UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 2
229920001864 tannin Polymers 0.000 description 2
235000018553 tannin Nutrition 0.000 description 2
239000001648 tannin Substances 0.000 description 2
239000012085 test solution Substances 0.000 description 2
230000001225 therapeutic effect Effects 0.000 description 2
231100000167 toxic agent Toxicity 0.000 description 2
201000008827 tuberculosis Diseases 0.000 description 2
241000712461 unidentified influenza virus Species 0.000 description 2
241001430294 unidentified retrovirus Species 0.000 description 2
208000019206 urinary tract infection Diseases 0.000 description 2
238000002255 vaccination Methods 0.000 description 2
230000029812 viral genome replication Effects 0.000 description 2
238000005303 weighing Methods 0.000 description 2
FUFLCEKSBBHCMO-UHFFFAOYSA-N 11-dehydrocorticosterone Natural products O=C1CCC2(C)C3C(=O)CC(C)(C(CC4)C(=O)CO)C4C3CCC2=C1 FUFLCEKSBBHCMO-UHFFFAOYSA-N 0.000 description 1
VZSRBBMJRBPUNF-UHFFFAOYSA-N 2-(2,3-dihydro-1H-inden-2-ylamino)-N-[3-oxo-3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propyl]pyrimidine-5-carboxamide Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C(=O)NCCC(N1CC2=C(CC1)NN=N2)=O VZSRBBMJRBPUNF-UHFFFAOYSA-N 0.000 description 1
MSWZFWKMSRAUBD-IVMDWMLBSA-N 2-amino-2-deoxy-D-glucopyranose Chemical compound N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O MSWZFWKMSRAUBD-IVMDWMLBSA-N 0.000 description 1
QGJZLNKBHJESQX-UHFFFAOYSA-N 3-Epi-Betulin-Saeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C(=C)C)C5C4CCC3C21C QGJZLNKBHJESQX-UHFFFAOYSA-N 0.000 description 1
CLOUCVRNYSHRCF-UHFFFAOYSA-N 3beta-Hydroxy-20(29)-Lupen-3,27-oic acid Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C(O)=O)CCC5(C)CCC(C(=C)C)C5C4CCC3C21C CLOUCVRNYSHRCF-UHFFFAOYSA-N 0.000 description 1
CJIJXIFQYOPWTF-UHFFFAOYSA-N 7-hydroxycoumarin Natural products O1C(=O)C=CC2=CC(O)=CC=C21 CJIJXIFQYOPWTF-UHFFFAOYSA-N 0.000 description 1
229940124718 AIDS vaccine Drugs 0.000 description 1
208000004998 Abdominal Pain Diseases 0.000 description 1
206010000087 Abdominal pain upper Diseases 0.000 description 1
208000002874 Acne Vulgaris Diseases 0.000 description 1
241000227129 Aconitum Species 0.000 description 1
201000004384 Alopecia Diseases 0.000 description 1
QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical class [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
206010002091 Anaesthesia Diseases 0.000 description 1
240000007087 Apium graveolens Species 0.000 description 1
235000015849 Apium graveolens Dulce Group Nutrition 0.000 description 1
235000010591 Appio Nutrition 0.000 description 1
101100519969 Arabidopsis thaliana PHS2 gene Proteins 0.000 description 1
NOWKCMXCCJGMRR-UHFFFAOYSA-N Aziridine Chemical compound C1CN1 NOWKCMXCCJGMRR-UHFFFAOYSA-N 0.000 description 1
241000894006 Bacteria Species 0.000 description 1
208000035143 Bacterial infection Diseases 0.000 description 1
239000005711 Benzoic acid Substances 0.000 description 1
DIZWSDNSTNAYHK-XGWVBXMLSA-N Betulinic acid Natural products CC(=C)[C@@H]1C[C@H]([C@H]2CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@@]34C)[C@@H]12)C(=O)O DIZWSDNSTNAYHK-XGWVBXMLSA-N 0.000 description 1
241001148763 Blechnum Species 0.000 description 1
241001313855 Bletilla Species 0.000 description 1
108091003079 Bovine Serum Albumin Proteins 0.000 description 1
241000219193 Brassicaceae Species 0.000 description 1
206010006187 Breast cancer Diseases 0.000 description 1
208000026310 Breast neoplasm Diseases 0.000 description 1
108010041397 CD4 Antigens Proteins 0.000 description 1
QAGYKUNXZHXKMR-UHFFFAOYSA-N CPD000469186 Natural products CC1=C(O)C=CC=C1C(=O)NC(C(O)CN1C(CC2CCCCC2C1)C(=O)NC(C)(C)C)CSC1=CC=CC=C1 QAGYKUNXZHXKMR-UHFFFAOYSA-N 0.000 description 1
240000006620 Calla palustris Species 0.000 description 1
235000004012 Calla palustris Nutrition 0.000 description 1
208000005623 Carcinogenesis Diseases 0.000 description 1
208000002177 Cataract Diseases 0.000 description 1
241000269333 Caudata Species 0.000 description 1
102000019034 Chemokines Human genes 0.000 description 1
108010012236 Chemokines Proteins 0.000 description 1
208000017667 Chronic Disease Diseases 0.000 description 1
101150065749 Churc1 gene Proteins 0.000 description 1
208000035473 Communicable disease Diseases 0.000 description 1
206010010741 Conjunctivitis Diseases 0.000 description 1
206010010774 Constipation Diseases 0.000 description 1
241000207782 Convolvulaceae Species 0.000 description 1
MFYSYFVPBJMHGN-ZPOLXVRWSA-N Cortisone Chemical compound O=C1CC[C@]2(C)[C@H]3C(=O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 MFYSYFVPBJMHGN-ZPOLXVRWSA-N 0.000 description 1
MFYSYFVPBJMHGN-UHFFFAOYSA-N Cortisone Natural products O=C1CCC2(C)C3C(=O)CC(C)(C(CC4)(O)C(=O)CO)C4C3CCC2=C1 MFYSYFVPBJMHGN-UHFFFAOYSA-N 0.000 description 1
241001660870 Cyrtomium Species 0.000 description 1
108020003215 DNA Probes Proteins 0.000 description 1
239000003298 DNA probe Substances 0.000 description 1
102000004163 DNA-directed RNA polymerases Human genes 0.000 description 1
108090000626 DNA-directed RNA polymerases Proteins 0.000 description 1
206010012335 Dependence Diseases 0.000 description 1
208000012239 Developmental disease Diseases 0.000 description 1
BXZVVICBKDXVGW-NKWVEPMBSA-N Didanosine Chemical compound O1[C@H](CO)CC[C@@H]1N1C(NC=NC2=O)=C2N=C1 BXZVVICBKDXVGW-NKWVEPMBSA-N 0.000 description 1
240000001879 Digitalis lutea Species 0.000 description 1
101100136092 Drosophila melanogaster peng gene Proteins 0.000 description 1
208000005171 Dysmenorrhea Diseases 0.000 description 1
206010013935 Dysmenorrhoea Diseases 0.000 description 1
KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
238000002965 ELISA Methods 0.000 description 1
241000991587 Enterovirus C Species 0.000 description 1
206010015150 Erythema Diseases 0.000 description 1
244000061408 Eugenia caryophyllata Species 0.000 description 1
DTOUWTJYUCZJQD-UJERWXFOSA-N Forsythiaside Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1OC[C@@H]1[C@@H](OC(=O)\C=C\C=2C=C(O)C(O)=CC=2)[C@H](O)[C@@H](O)[C@H](OCCC=2C=C(O)C(O)=CC=2)O1 DTOUWTJYUCZJQD-UJERWXFOSA-N 0.000 description 1
DTOUWTJYUCZJQD-QJDQKFITSA-N Forsythiaside Natural products C[C@@H]1O[C@H](OC[C@H]2O[C@@H](OCCc3ccc(O)c(O)c3)[C@H](O)[C@@H](O)[C@@H]2OC(=O)C=Cc4ccc(O)c(O)c4)[C@H](O)[C@H](O)[C@H]1O DTOUWTJYUCZJQD-QJDQKFITSA-N 0.000 description 1
240000007108 Fuchsia magellanica Species 0.000 description 1
244000044980 Fumaria officinalis Species 0.000 description 1
235000006961 Fumaria officinalis Nutrition 0.000 description 1
229910052688 Gadolinium Inorganic materials 0.000 description 1
201000003741 Gastrointestinal carcinoma Diseases 0.000 description 1
241000202807 Glycyrrhiza Species 0.000 description 1
239000004378 Glycyrrhizin Substances 0.000 description 1
208000031957 HIV carrier Diseases 0.000 description 1
208000000616 Hemoptysis Diseases 0.000 description 1
208000032843 Hemorrhage Diseases 0.000 description 1
208000005331 Hepatitis D Diseases 0.000 description 1
206010019773 Hepatitis G Diseases 0.000 description 1
208000037319 Hepatitis infectious Diseases 0.000 description 1
206010019799 Hepatitis viral Diseases 0.000 description 1
244000084296 Hernandia moerenhoutiana Species 0.000 description 1
235000010044 Hernandia moerenhoutiana Nutrition 0.000 description 1
208000029433 Herpesviridae infectious disease Diseases 0.000 description 1
206010021118 Hypotonia Diseases 0.000 description 1
XQFRJNBWHJMXHO-RRKCRQDMSA-N IDUR Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(I)=C1 XQFRJNBWHJMXHO-RRKCRQDMSA-N 0.000 description 1
241000519695 Ilex integra Species 0.000 description 1
206010061598 Immunodeficiency Diseases 0.000 description 1
208000029462 Immunodeficiency disease Diseases 0.000 description 1
235000000177 Indigofera tinctoria Nutrition 0.000 description 1
102000000588 Interleukin-2 Human genes 0.000 description 1
108010002350 Interleukin-2 Proteins 0.000 description 1
WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 1
241000207923 Lamiaceae Species 0.000 description 1
201000008197 Laryngitis Diseases 0.000 description 1
241000522169 Lespedeza Species 0.000 description 1
206010025282 Lymphoedema Diseases 0.000 description 1
208000037093 Menstruation Disturbances Diseases 0.000 description 1
206010027339 Menstruation irregular Diseases 0.000 description 1
241000699666 Mus <mouse, genus> Species 0.000 description 1
208000010428 Muscle Weakness Diseases 0.000 description 1
206010028372 Muscular weakness Diseases 0.000 description 1
235000006508 Nelumbo nucifera Nutrition 0.000 description 1
240000002853 Nelumbo nucifera Species 0.000 description 1
235000006510 Nelumbo pentapetala Nutrition 0.000 description 1
208000007443 Neurasthenia Diseases 0.000 description 1
241000207834 Oleaceae Species 0.000 description 1
108091034117 Oligonucleotide Proteins 0.000 description 1
241000233855 Orchidaceae Species 0.000 description 1
241000238814 Orthoptera Species 0.000 description 1
241000283973 Oryctolagus cuniculus Species 0.000 description 1
206010031252 Osteomyelitis Diseases 0.000 description 1
244000236658 Paeonia lactiflora Species 0.000 description 1
235000008598 Paeonia lactiflora Nutrition 0.000 description 1
229930182555 Penicillin Natural products 0.000 description 1
JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
206010057249 Phagocytosis Diseases 0.000 description 1
206010035664 Pneumonia Diseases 0.000 description 1
241001417524 Pomacanthidae Species 0.000 description 1
XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 description 1
208000003251 Pruritus Diseases 0.000 description 1
201000004681 Psoriasis Diseases 0.000 description 1
241001116757 Pyrrosia lingua Species 0.000 description 1
239000010075 Qingdai compound Substances 0.000 description 1
239000013614 RNA sample Substances 0.000 description 1
239000012980 RPMI-1640 medium Substances 0.000 description 1
241000218206 Ranunculus Species 0.000 description 1
QNVSXXGDAPORNA-UHFFFAOYSA-N Resveratrol Natural products OC1=CC=CC(C=CC=2C=C(O)C(O)=CC=2)=C1 QNVSXXGDAPORNA-UHFFFAOYSA-N 0.000 description 1
NCDNCNXCDXHOMX-UHFFFAOYSA-N Ritonavir Natural products C=1C=CC=CC=1CC(NC(=O)OCC=1SC=NC=1)C(O)CC(CC=1C=CC=CC=1)NC(=O)C(C(C)C)NC(=O)N(C)CC1=CSC(C(C)C)=N1 NCDNCNXCDXHOMX-UHFFFAOYSA-N 0.000 description 1
241001107098 Rubiaceae Species 0.000 description 1
241001093501 Rutaceae Species 0.000 description 1
244000057114 Sapium sebiferum Species 0.000 description 1
235000005128 Sapium sebiferum Nutrition 0.000 description 1
206010040047 Sepsis Diseases 0.000 description 1
241000700584 Simplexvirus Species 0.000 description 1
208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
208000004078 Snake Bites Diseases 0.000 description 1
241000208292 Solanaceae Species 0.000 description 1
235000002634 Solanum Nutrition 0.000 description 1
241000207763 Solanum Species 0.000 description 1
229920002472 Starch Polymers 0.000 description 1
229910000831 Steel Inorganic materials 0.000 description 1
208000007107 Stomach Ulcer Diseases 0.000 description 1
IAXBXCJUSPUULA-AQXOCQMTSA-N Suspensaside Natural products O=C(O[C@H]1[C@H](O)[C@@H](O)[C@H](OC[C@@H](O)c2cc(O)c(O)cc2)O[C@H]1CO[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@@H](C)O1)/C=C/c1cc(O)c(O)cc1 IAXBXCJUSPUULA-AQXOCQMTSA-N 0.000 description 1
206010042674 Swelling Diseases 0.000 description 1
244000223014 Syzygium aromaticum Species 0.000 description 1
210000001744 T-lymphocyte Anatomy 0.000 description 1
229920002253 Tannate Polymers 0.000 description 1
LUKBXSAWLPMMSZ-OWOJBTEDSA-N Trans-resveratrol Chemical compound C1=CC(O)=CC=C1\C=C\C1=CC(O)=CC(O)=C1 LUKBXSAWLPMMSZ-OWOJBTEDSA-N 0.000 description 1
239000007983 Tris buffer Substances 0.000 description 1
208000025865 Ulcer Diseases 0.000 description 1
206010046543 Urinary incontinence Diseases 0.000 description 1
208000016599 Uterine disease Diseases 0.000 description 1
244000137773 Viola philippica Species 0.000 description 1
108010015780 Viral Core Proteins Proteins 0.000 description 1
108020000999 Viral RNA Proteins 0.000 description 1
206010047700 Vomiting Diseases 0.000 description 1
208000027418 Wounds and injury Diseases 0.000 description 1
IAXBXCJUSPUULA-RHTWPPHESA-N [(2r,3s,4r,5r,6r)-6-[2-(3,4-dihydroxyphenyl)-2-hydroxyethoxy]-4,5-dihydroxy-2-[[(2r,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxymethyl]oxan-3-yl] (e)-3-(3,4-dihydroxyphenyl)prop-2-enoate Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1OC[C@@H]1[C@@H](OC(=O)\C=C\C=2C=C(O)C(O)=CC=2)[C@H](O)[C@@H](O)[C@H](OCC(O)C=2C=C(O)C(O)=CC=2)O1 IAXBXCJUSPUULA-RHTWPPHESA-N 0.000 description 1
ZYVVPOVJIAXSNT-UHFFFAOYSA-N [Th+4].[N-]=[N+]=[N-].[N-]=[N+]=[N-].[N-]=[N+]=[N-].[N-]=[N+]=[N-] Chemical compound [Th+4].[N-]=[N+]=[N-].[N-]=[N+]=[N-].[N-]=[N+]=[N-].[N-]=[N+]=[N-] ZYVVPOVJIAXSNT-UHFFFAOYSA-N 0.000 description 1
239000002250 absorbent Substances 0.000 description 1
230000002745 absorbent Effects 0.000 description 1
WDJHALXBUFZDSR-UHFFFAOYSA-M acetoacetate Chemical compound CC(=O)CC([O-])=O WDJHALXBUFZDSR-UHFFFAOYSA-M 0.000 description 1
102000005421 acetyltransferase Human genes 0.000 description 1
108020002494 acetyltransferase Proteins 0.000 description 1
206010000496 acne Diseases 0.000 description 1
239000012190 activator Substances 0.000 description 1
231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 1
231100000354 acute hepatitis Toxicity 0.000 description 1
208000038016 acute inflammation Diseases 0.000 description 1
230000006022 acute inflammation Effects 0.000 description 1
238000011047 acute toxicity test Methods 0.000 description 1
239000003463 adsorbent Substances 0.000 description 1
150000001298 alcohols Chemical class 0.000 description 1
150000001409 amidines Chemical class 0.000 description 1
230000037005 anaesthesia Effects 0.000 description 1
238000001949 anaesthesia Methods 0.000 description 1
230000003444 anaesthetic effect Effects 0.000 description 1
229940035676 analgesics Drugs 0.000 description 1
208000007502 anemia Diseases 0.000 description 1
150000001450 anions Chemical class 0.000 description 1
239000000730 antalgic agent Substances 0.000 description 1
239000002259 anti human immunodeficiency virus agent Substances 0.000 description 1
230000001773 anti-convulsant effect Effects 0.000 description 1
230000000843 anti-fungal effect Effects 0.000 description 1
229940124411 anti-hiv antiviral agent Drugs 0.000 description 1
238000002832 anti-viral assay Methods 0.000 description 1
239000001961 anticonvulsive agent Substances 0.000 description 1
229960003965 antiepileptics Drugs 0.000 description 1
229940121375 antifungal agent Drugs 0.000 description 1
239000002246 antineoplastic agent Substances 0.000 description 1
229940125716 antipyretic agent Drugs 0.000 description 1
239000003434 antitussive agent Substances 0.000 description 1
229940124584 antitussives Drugs 0.000 description 1
230000036528 appetite Effects 0.000 description 1
235000019789 appetite Nutrition 0.000 description 1
125000003118 aryl group Chemical group 0.000 description 1
206010003549 asthenia Diseases 0.000 description 1
235000019606 astringent taste Nutrition 0.000 description 1
239000012298 atmosphere Substances 0.000 description 1
230000001363 autoimmune Effects 0.000 description 1
210000003403 autonomic nervous system Anatomy 0.000 description 1
230000001580 bacterial effect Effects 0.000 description 1
208000022362 bacterial infectious disease Diseases 0.000 description 1
230000003542 behavioural effect Effects 0.000 description 1
230000008901 benefit Effects 0.000 description 1
235000010233 benzoic acid Nutrition 0.000 description 1
235000021028 berry Nutrition 0.000 description 1
MSWZFWKMSRAUBD-UHFFFAOYSA-N beta-D-galactosamine Natural products NC1C(O)OC(CO)C(O)C1O MSWZFWKMSRAUBD-UHFFFAOYSA-N 0.000 description 1
QGJZLNKBHJESQX-FZFNOLFKSA-N betulinic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CC[C@@H](C(=C)C)[C@@H]5[C@H]4CC[C@@H]3[C@]21C QGJZLNKBHJESQX-FZFNOLFKSA-N 0.000 description 1
230000005540 biological transmission Effects 0.000 description 1
208000034158 bleeding Diseases 0.000 description 1
230000000740 bleeding effect Effects 0.000 description 1
230000023555 blood coagulation Effects 0.000 description 1
230000037396 body weight Effects 0.000 description 1
201000003516 breast abscess Diseases 0.000 description 1
229910001424 calcium ion Inorganic materials 0.000 description 1
238000011088 calibration curve Methods 0.000 description 1
230000036952 cancer formation Effects 0.000 description 1
150000001720 carbohydrates Chemical class 0.000 description 1
235000014633 carbohydrates Nutrition 0.000 description 1
231100000504 carcinogenesis Toxicity 0.000 description 1
238000001516 cell proliferation assay Methods 0.000 description 1
239000006285 cell suspension Substances 0.000 description 1
230000007541 cellular toxicity Effects 0.000 description 1
210000003169 central nervous system Anatomy 0.000 description 1
210000003756 cervix mucus Anatomy 0.000 description 1
238000012512 characterization method Methods 0.000 description 1
BJDCWCLMFKKGEE-CMDXXVQNSA-N chembl252518 Chemical compound C([C@@](OO1)(C)O2)C[C@H]3[C@H](C)CC[C@@H]4[C@@]31[C@@H]2O[C@H](O)[C@@H]4C BJDCWCLMFKKGEE-CMDXXVQNSA-N 0.000 description 1
238000001311 chemical methods and process Methods 0.000 description 1
238000006243 chemical reaction Methods 0.000 description 1
238000011097 chromatography purification Methods 0.000 description 1
201000005547 chronic conjunctivitis Diseases 0.000 description 1
230000001684 chronic effect Effects 0.000 description 1
239000011248 coating agent Substances 0.000 description 1
238000000576 coating method Methods 0.000 description 1
239000003086 colorant Substances 0.000 description 1
238000007398 colorimetric assay Methods 0.000 description 1
238000004440 column chromatography Methods 0.000 description 1
230000001010 compromised effect Effects 0.000 description 1
239000000356 contaminant Substances 0.000 description 1
238000011109 contamination Methods 0.000 description 1
238000013270 controlled release Methods 0.000 description 1
229960004544 cortisone Drugs 0.000 description 1
235000020247 cow milk Nutrition 0.000 description 1
239000006071 cream Substances 0.000 description 1
229940088900 crixivan Drugs 0.000 description 1
210000003464 cuspid Anatomy 0.000 description 1
230000001085 cytostatic effect Effects 0.000 description 1
231100000263 cytotoxicity test Toxicity 0.000 description 1
230000002354 daily effect Effects 0.000 description 1
229960005319 delavirdine Drugs 0.000 description 1
230000006866 deterioration Effects 0.000 description 1
238000011161 development Methods 0.000 description 1
230000018109 developmental process Effects 0.000 description 1
206010012601 diabetes mellitus Diseases 0.000 description 1
238000003745 diagnosis Methods 0.000 description 1
229960002656 didanosine Drugs 0.000 description 1
PZXJOHSZQAEJFE-UHFFFAOYSA-N dihydrobetulinic acid Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C(C)C)C5C4CCC3C21C PZXJOHSZQAEJFE-UHFFFAOYSA-N 0.000 description 1
230000008034 disappearance Effects 0.000 description 1
230000006806 disease prevention Effects 0.000 description 1
208000035475 disorder Diseases 0.000 description 1
230000001882 diuretic effect Effects 0.000 description 1
239000002552 dosage form Substances 0.000 description 1
235000011869 dried fruits Nutrition 0.000 description 1
230000035622 drinking Effects 0.000 description 1
239000006196 drop Substances 0.000 description 1
241001493065 dsRNA viruses Species 0.000 description 1
201000006549 dyspepsia Diseases 0.000 description 1
206010014599 encephalitis Diseases 0.000 description 1
238000001952 enzyme assay Methods 0.000 description 1
229940072253 epivir Drugs 0.000 description 1
238000012869 ethanol precipitation Methods 0.000 description 1
239000000469 ethanolic extract Substances 0.000 description 1
238000011156 evaluation Methods 0.000 description 1
230000003203 everyday effect Effects 0.000 description 1
238000013213 extrapolation Methods 0.000 description 1
239000003889 eye drop Substances 0.000 description 1
229940012356 eye drops Drugs 0.000 description 1
239000012894 fetal calf serum Substances 0.000 description 1
210000002950 fibroblast Anatomy 0.000 description 1
239000000945 filler Substances 0.000 description 1
229930003935 flavonoid Natural products 0.000 description 1
150000002215 flavonoids Chemical class 0.000 description 1
235000017173 flavonoids Nutrition 0.000 description 1
238000009472 formulation Methods 0.000 description 1
UIWYJDYFSGRHKR-UHFFFAOYSA-N gadolinium atom Chemical compound [Gd] UIWYJDYFSGRHKR-UHFFFAOYSA-N 0.000 description 1
201000005917 gastric ulcer Diseases 0.000 description 1
239000000499 gel Substances 0.000 description 1
229960002442 glucosamine Drugs 0.000 description 1
229930195712 glutamate Natural products 0.000 description 1
LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 1
229960004949 glycyrrhizic acid Drugs 0.000 description 1
UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 1
235000019410 glycyrrhizin Nutrition 0.000 description 1
LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 1
230000005484 gravity Effects 0.000 description 1
230000035931 haemagglutination Effects 0.000 description 1
230000003676 hair loss Effects 0.000 description 1
125000001475 halogen functional group Chemical group 0.000 description 1
230000005802 health problem Effects 0.000 description 1
210000000087 hemolymph Anatomy 0.000 description 1
208000014617 hemorrhoid Diseases 0.000 description 1
201000010284 hepatitis E Diseases 0.000 description 1
239000012676 herbal extract Substances 0.000 description 1
239000002035 hexane extract Substances 0.000 description 1
238000012781 high pressure - size exclusion chromatography Methods 0.000 description 1
210000005260 human cell Anatomy 0.000 description 1
210000005104 human peripheral blood lymphocyte Anatomy 0.000 description 1
150000007857 hydrazones Chemical class 0.000 description 1
229910052739 hydrogen Inorganic materials 0.000 description 1
208000003532 hypothyroidism Diseases 0.000 description 1
230000001900 immune effect Effects 0.000 description 1
238000002649 immunization Methods 0.000 description 1
230000003053 immunization Effects 0.000 description 1
230000007813 immunodeficiency Effects 0.000 description 1
230000002779 inactivation Effects 0.000 description 1
229940097275 indigo Drugs 0.000 description 1
COHYTHOBJLSHDF-UHFFFAOYSA-N indigo powder Natural products N1C2=CC=CC=C2C(=O)C1=C1C(=O)C2=CC=CC=C2N1 COHYTHOBJLSHDF-UHFFFAOYSA-N 0.000 description 1
229960001936 indinavir Drugs 0.000 description 1
230000002757 inflammatory effect Effects 0.000 description 1
230000001309 inhibitory effect on influenza Effects 0.000 description 1
238000011221 initial treatment Methods 0.000 description 1
208000014674 injury Diseases 0.000 description 1
239000000077 insect repellent Substances 0.000 description 1
206010022437 insomnia Diseases 0.000 description 1
230000003993 interaction Effects 0.000 description 1
230000002452 interceptive effect Effects 0.000 description 1
201000002313 intestinal cancer Diseases 0.000 description 1
208000011140 intestinal infectious disease Diseases 0.000 description 1
210000000936 intestine Anatomy 0.000 description 1
229940088976 invirase Drugs 0.000 description 1
LTINPJMVDKPJJI-UHFFFAOYSA-N iodinated glycerol Chemical compound CC(I)C1OCC(CO)O1 LTINPJMVDKPJJI-UHFFFAOYSA-N 0.000 description 1
229910052742 iron Inorganic materials 0.000 description 1
238000002955 isolation Methods 0.000 description 1
230000007803 itching Effects 0.000 description 1
JPUKWEQWGBDDQB-QSOFNFLRSA-N kaempferol 3-O-beta-D-glucoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=C(C=2C=CC(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O JPUKWEQWGBDDQB-QSOFNFLRSA-N 0.000 description 1
206010023332 keratitis Diseases 0.000 description 1
208000017169 kidney disease Diseases 0.000 description 1
229960001627 lamivudine Drugs 0.000 description 1
229910052745 lead Inorganic materials 0.000 description 1
235000021374 legumes Nutrition 0.000 description 1
GZQKNULLWNGMCW-PWQABINMSA-N lipid A (E. coli) Chemical compound O1[C@H](CO)[C@@H](OP(O)(O)=O)[C@H](OC(=O)C[C@@H](CCCCCCCCCCC)OC(=O)CCCCCCCCCCCCC)[C@@H](NC(=O)C[C@@H](CCCCCCCCCCC)OC(=O)CCCCCCCCCCC)[C@@H]1OC[C@@H]1[C@@H](O)[C@H](OC(=O)C[C@H](O)CCCCCCCCCCC)[C@@H](NC(=O)C[C@H](O)CCCCCCCCCCC)[C@@H](OP(O)(O)=O)O1 GZQKNULLWNGMCW-PWQABINMSA-N 0.000 description 1
210000001165 lymph node Anatomy 0.000 description 1
201000007227 lymph node tuberculosis Diseases 0.000 description 1
208000002502 lymphedema Diseases 0.000 description 1
229920002521 macromolecule Polymers 0.000 description 1
229910001425 magnesium ion Inorganic materials 0.000 description 1
238000003760 magnetic stirring Methods 0.000 description 1
VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 description 1
239000000845 maltitol Substances 0.000 description 1
229940035436 maltitol Drugs 0.000 description 1
235000010449 maltitol Nutrition 0.000 description 1
230000007246 mechanism Effects 0.000 description 1
238000005374 membrane filtration Methods 0.000 description 1
230000005906 menstruation Effects 0.000 description 1
229910052753 mercury Inorganic materials 0.000 description 1
239000002207 metabolite Substances 0.000 description 1
125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
230000000813 microbial effect Effects 0.000 description 1
235000013336 milk Nutrition 0.000 description 1
239000008267 milk Substances 0.000 description 1
238000012986 modification Methods 0.000 description 1
230000004048 modification Effects 0.000 description 1
210000005087 mononuclear cell Anatomy 0.000 description 1
210000002864 mononuclear phagocyte Anatomy 0.000 description 1
239000004570 mortar (masonry) Substances 0.000 description 1
230000036640 muscle relaxation Effects 0.000 description 1
229960000884 nelfinavir Drugs 0.000 description 1
QAGYKUNXZHXKMR-HKWSIXNMSA-N nelfinavir Chemical compound CC1=C(O)C=CC=C1C(=O)N[C@H]([C@H](O)CN1[C@@H](C[C@@H]2CCCC[C@@H]2C1)C(=O)NC(C)(C)C)CSC1=CC=CC=C1 QAGYKUNXZHXKMR-HKWSIXNMSA-N 0.000 description 1
MQYXUWHLBZFQQO-UHFFFAOYSA-N nepehinol Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C)CCC(C(=C)C)C5C4CCC3C21C MQYXUWHLBZFQQO-UHFFFAOYSA-N 0.000 description 1
201000008383 nephritis Diseases 0.000 description 1
210000000653 nervous system Anatomy 0.000 description 1
229960000689 nevirapine Drugs 0.000 description 1
229910052757 nitrogen Inorganic materials 0.000 description 1
231100000957 no side effect Toxicity 0.000 description 1
231100000956 nontoxicity Toxicity 0.000 description 1
VIKNJXKGJWUCNN-XGXHKTLJSA-N norethisterone Chemical compound O=C1CC[C@@H]2[C@H]3CC[C@](C)([C@](CC4)(O)C#C)[C@@H]4[C@@H]3CCC2=C1 VIKNJXKGJWUCNN-XGXHKTLJSA-N 0.000 description 1
229940072250 norvir Drugs 0.000 description 1
238000007899 nucleic acid hybridization Methods 0.000 description 1
150000002894 organic compounds Chemical class 0.000 description 1
210000003254 palate Anatomy 0.000 description 1
229940049954 penicillin Drugs 0.000 description 1
210000003819 peripheral blood mononuclear cell Anatomy 0.000 description 1
230000008782 phagocytosis Effects 0.000 description 1
239000008177 pharmaceutical agent Substances 0.000 description 1
230000000144 pharmacologic effect Effects 0.000 description 1
239000008363 phosphate buffer Substances 0.000 description 1
229910052698 phosphorus Inorganic materials 0.000 description 1
230000010399 physical interaction Effects 0.000 description 1
239000002504 physiological saline solution Substances 0.000 description 1
238000005554 pickling Methods 0.000 description 1
239000006187 pill Substances 0.000 description 1
238000004321 preservation Methods 0.000 description 1
230000008569 process Effects 0.000 description 1
238000012545 processing Methods 0.000 description 1
230000002250 progressing effect Effects 0.000 description 1
239000008213 purified water Substances 0.000 description 1
GJAWHXHKYYXBSV-UHFFFAOYSA-N quinolinic acid Chemical compound OC(=O)C1=CC=CN=C1C(O)=O GJAWHXHKYYXBSV-UHFFFAOYSA-N 0.000 description 1
230000011514 reflex Effects 0.000 description 1
238000001226 reprecipitation Methods 0.000 description 1
229940063627 rescriptor Drugs 0.000 description 1
208000023504 respiratory system disease Diseases 0.000 description 1
235000021283 resveratrol Nutrition 0.000 description 1
229940016667 resveratrol Drugs 0.000 description 1
230000001177 retroviral effect Effects 0.000 description 1
230000002441 reversible effect Effects 0.000 description 1
229960000311 ritonavir Drugs 0.000 description 1
239000012266 salt solution Substances 0.000 description 1
238000003118 sandwich ELISA Methods 0.000 description 1
229930182490 saponin Natural products 0.000 description 1
235000017709 saponins Nutrition 0.000 description 1
150000007949 saponins Chemical class 0.000 description 1
230000002784 sclerotic effect Effects 0.000 description 1
RODXRVNMMDRFIK-UHFFFAOYSA-N scopoletin Chemical compound C1=CC(=O)OC2=C1C=C(OC)C(O)=C2 RODXRVNMMDRFIK-UHFFFAOYSA-N 0.000 description 1
238000012216 screening Methods 0.000 description 1
230000035945 sensitivity Effects 0.000 description 1
208000013223 septicemia Diseases 0.000 description 1
208000015891 sexual disease Diseases 0.000 description 1
239000011780 sodium chloride Substances 0.000 description 1
159000000000 sodium salts Chemical class 0.000 description 1
238000001179 sorption measurement Methods 0.000 description 1
235000019614 sour taste Nutrition 0.000 description 1
238000004611 spectroscopical analysis Methods 0.000 description 1
239000008107 starch Substances 0.000 description 1
235000019698 starch Nutrition 0.000 description 1
125000004079 stearyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
239000010959 steel Substances 0.000 description 1
230000001954 sterilising effect Effects 0.000 description 1
238000004659 sterilization and disinfection Methods 0.000 description 1
230000004936 stimulating effect Effects 0.000 description 1
210000002784 stomach Anatomy 0.000 description 1
229960005322 streptomycin Drugs 0.000 description 1
229910052717 sulfur Inorganic materials 0.000 description 1
239000013589 supplement Substances 0.000 description 1
230000004083 survival effect Effects 0.000 description 1
230000002459 sustained effect Effects 0.000 description 1
235000019605 sweet taste sensations Nutrition 0.000 description 1
230000008961 swelling Effects 0.000 description 1
208000011580 syndromic disease Diseases 0.000 description 1
230000002195 synergetic effect Effects 0.000 description 1
208000006379 syphilis Diseases 0.000 description 1
QJVXKWHHAMZTBY-GCPOEHJPSA-N syringin Chemical compound COC1=CC(\C=C\CO)=CC(OC)=C1O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 QJVXKWHHAMZTBY-GCPOEHJPSA-N 0.000 description 1
QJVXKWHHAMZTBY-KSXIZUIISA-N syringin Natural products COc1cc(C=CCO)cc(OC)c1O[C@H]2O[C@@H](CO)[C@H](O)[C@@H](O)[C@@H]2O QJVXKWHHAMZTBY-KSXIZUIISA-N 0.000 description 1
239000003826 tablet Substances 0.000 description 1
235000013616 tea Nutrition 0.000 description 1
206010043778 thyroiditis Diseases 0.000 description 1
210000001519 tissue Anatomy 0.000 description 1
230000001256 tonic effect Effects 0.000 description 1
206010044008 tonsillitis Diseases 0.000 description 1
239000003440 toxic substance Substances 0.000 description 1
238000012546 transfer Methods 0.000 description 1
LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
ORHBXUUXSCNDEV-UHFFFAOYSA-N umbelliferone Chemical compound C1=CC(=O)OC2=CC(O)=CC=C21 ORHBXUUXSCNDEV-UHFFFAOYSA-N 0.000 description 1
HFTAFOQKODTIJY-UHFFFAOYSA-N umbelliferone Natural products Cc1cc2C=CC(=O)Oc2cc1OCC=CC(C)(C)O HFTAFOQKODTIJY-UHFFFAOYSA-N 0.000 description 1
208000000143 urethritis Diseases 0.000 description 1
229960005486 vaccine Drugs 0.000 description 1
206010046901 vaginal discharge Diseases 0.000 description 1
230000002792 vascular Effects 0.000 description 1
201000001862 viral hepatitis Diseases 0.000 description 1
210000002845 virion Anatomy 0.000 description 1
230000008673 vomiting Effects 0.000 description 1
230000029663 wound healing Effects 0.000 description 1
235000013618 yogurt Nutrition 0.000 description 1
229960000523 zalcitabine Drugs 0.000 description 1